Estado de evaluación del expediente

Estado de evaluación del expediente

Data platform availability banner - dossier evaluation status

The new ECHA CHEM database has been released by ECHA. See for more information on the transition to ECHA CHEM.  More

Please be aware that REACH registration data on the current Dissemination Platform (accessible through the magnifying glass icon in the table) is no longer maintained; it remains frozen as of 19th May 2023. As shown in the support page we hope to move the dossier evaluation information to ECHA CHEM by the end of 2024. Until then, while the assessment status will be updated here, the corresponding registration dossiers will be available only on ECHA CHEM.

We appreciate your understanding during this transition period.


 

Estado de evaluación del expediente

ECHA’s dossier evaluation process covers compliance checks and the examination of testing proposals. By consulting the table below, you can find out whether ECHA has started to evaluate dossiers for a particular substance and follow the progress through the evaluation process.

The table below displays the type, scope and status of the assessment undertaken for a given dossier. The decision date and the non-confidential version of the decision are published shortly after the decision has been adopted.

Before publishing the non-confidential version of an adopted decision on its website, ECHA consults the addressees of the decision on this version. ECHA systematically removes any personal data from the non-confidential version of a decision. Some sections may also be redacted based on justified claims by registrants, regarding information confidential or deemed to harm their commercial interest if disclosed.

Check the expandable boxes below for more details.

 

Content of the table

Identifiers of the substance: Name (as on the Dissemination website); EC/List number (European Community number / List number assigned by ECHA); CAS number (also called the Chemical Abstract Service Registry Number or CAS RN).

Decision type can be ‘CCH’ for Compliance Check Evaluation and ‘TPE’ for Testing Proposal Evaluation.

Scope refers to the scope of the evaluation and can be:

  • Targeted: The compliance check focuses only on some endpoints.
  • Comprehensive: The compliance check focuses on all relevant endpoints under ECHA’s strategy.
  • Testing proposal: The assessment focuses on the testing proposals submitted by the registrants.

Status reports the current position of the dossier in the dossier evaluation process and can be:

  • Under assessment: The evaluation of the dossier has formally started.
  • Ongoing: The registrants have received the draft decision - The dossier retains this status until the decision is adopted or the evaluation is otherwise concluded.
  • Information requested: The registrants have received the adopted decision with the deadline for providing the requested information.
  • Follow-up: The deadline set in the adopted decision has passed, and ECHA is assessing whether the information requested in the decision has been provided in the dossier update - This follow-up may also involve the national enforcement authorities.
  • Concluded: The evaluation is closed.
    In most cases, this means that the registrant has responded to the adopted decision with compliant information. However, as in some cases an evaluation is concluded at an earlier stage, an adopted decision is not always available for every evaluation marked as concluded.

Decision date reports the date on which the adopted decision was sent to the registrants.

Decision displays a non-confidential version of the adopted decision once available.

Latest update indicates the date of the latest automatic update carried out by ECHA’s information systems.

Unless confidentiality is claimed on the substance identifiers, you can access the disseminated registration dossiers for the substance in ECHA CHEM. From the table below, click on the substance name link to access the Substance Infocard. From there you will find a link to direct you to the ECHA CHEM substance Dashboard and the REACH registration dossier(s). You can also go directly to ECHA CHEM and search with substance identifiers. 

The magnifying glass icon leads to information on the current dissemination platform that has not been updated since May 2023. We apologise for the inconvenience and appreciate your understanding during the transition period. 

You can access additional information in ‘Details’ view, by clicking on the eye icon:

  • Substance identifiers
  • Decision type (CCH or TPE), scope and status of the evaluation, as in the main table
  • Decision’s deadline(s): The deadline(s) for requested information contained in the decision, should the decision contain more than one deadline
  • Appeal information: If the registrants have appealed against the adopted decision, a link to the Board of Appeal’s announcement document is provided.

 

How to read the table

ECHA’s information systems automatically update the status of dossier evaluations during the process. For transparency reasons, all dossier evaluation decisions will remain published. This also applies if the registrants have appealed or have updated the registration dossier as requested in the decision.

It is for the reader to verify the status of an evaluation: check the deadline of the decision, the indicated status of the evaluation, and the content of the registration dossier. The most recent registration data on a substance is available in the ECHA CHEM database; check also whether the Board of Appeal has taken a decision regarding any appeal.

 

Important notes:

  • The dossier evaluation decisions may not apply to all registrants that are part of a joint registration.
  • There may be a delay between the decision date and the actual publication of the adopted decision, which corresponds to the consultation on its non-confidential version and addressing any comments from the registrants.
Last updated 28 marzo 2024. Database contains 4138 unique substances/entries.
Filter the list
Decision's deadline:
Decision date:

The List does not contain any Substances.
Decision    
438-340-0
119344-86-4
CCH
Comprehensive
Concluded
26-nov-2022
View
Details
219-460-0
2439-35-2
CCH
Targeted
Concluded
26-nov-2022
View
Details
219-460-0
2439-35-2
CCH
Comprehensive
Under assessment
04-sep-2023
View
Details
219-460-0
2439-35-2
CCH
Targeted
Concluded
26-nov-2022
View
Details
423-630-1
-
CCH
Comprehensive
Concluded
11-oct-2023
View
Details
203-052-4
102-77-2
CCH
Targeted
Concluded
26-nov-2022
View
Details
BENZYL-2-NAPHTHYLETHER; BETA-NAPHTHYLBENZYLETHER (BON); BNE; BON; NIPAFAX BNE; SENSLON-50; ZO-1
405-490-3
613-62-7
CCH
Targeted
Concluded
26-nov-2022
View
Details
BENZYL-2-NAPHTHYLETHER; BETA-NAPHTHYLBENZYLETHER (BON); BNE; BON; NIPAFAX BNE; SENSLON-50; ZO-1
405-490-3
613-62-7
CCH
Comprehensive
Concluded
26-nov-2022
View
Details
908-912-9
1333-16-0
CCH
Comprehensive
Concluded
09-jun-2022
View
Details
695-977-9
1309955-79-0
TPE
Testing Proposal
Concluded
26-nov-2022
View
Details
228-768-4
6358-31-2
TPE
Testing Proposal
Under assessment
10-ene-2024
View
Details
229-419-9
6528-34-3
CCH
Targeted
Ongoing
19-may-2023
View
Details
607-255-2
236391-76-7
TPE
Testing Proposal
Concluded
26-nov-2022
View
Details
402-600-1
765-12-8
TPE
Testing Proposal
Concluded
26-nov-2022
View
Details
254-588-0
39670-09-2
TPE
Testing Proposal
Concluded
26-nov-2022
View
Details
254-588-0
39670-09-2
CCH
Comprehensive
Concluded
26-nov-2022
View
Details
817-828-0
80322-82-3
TPE
Testing Proposal
Ongoing
13-dic-2023
View
Details
235-834-6
13001-38-2
CCH
Comprehensive
Ongoing
28-ago-2023
View
Details
235-834-6
13001-38-2
CCH
Comprehensive
Ongoing
28-ago-2023
View
Details
927-442-5
15651-72-6
CCH
Targeted
Under assessment
11-mar-2024
View
Details
266-733-5
67584-55-8
CCH
Comprehensive
Concluded
26-nov-2022
View
Details
239-268-0
15214-89-8
CCH
Targeted
Concluded
26-nov-2022
View
Details
204-709-8
124-68-5
CCH
Comprehensive
Concluded
26-nov-2022
View
Details
204-709-8
124-68-5
CCH
Targeted
Concluded
26-nov-2022
View
Details
205-483-3
141-43-5
CCH
Comprehensive
Concluded
26-nov-2022
View
Details
426-650-9
191743-75-6
CCH
Comprehensive
Concluded
26-nov-2022
View
Details
601-238-3
113163-37-4
CCH
Targeted
Concluded
26-nov-2022
View
Details
701-218-5
-
CCH
Targeted
Concluded
26-nov-2022
View
Details
CG 25-369; IRGACURE 369; TK 11-319
404-360-3
119313-12-1
CCH
Comprehensive
Concluded
26-nov-2022
View
Details
CG 25-369; IRGACURE 369; TK 11-319
404-360-3
119313-12-1
CCH
Comprehensive
Concluded
26-nov-2022
View
Details
CG 25-369; IRGACURE 369; TK 11-319
404-360-3
119313-12-1
CCH
Comprehensive
Concluded
26-nov-2022
View
Details
CG 25-369; IRGACURE 369; TK 11-319
404-360-3
119313-12-1
CCH
Comprehensive
Concluded
26-nov-2022
View
Details
CG 25-369; IRGACURE 369; TK 11-319
404-360-3
119313-12-1
TPE
Testing Proposal
Concluded
26-nov-2022
Details
CG 25-369; IRGACURE 369; TK 11-319
404-360-3
119313-12-1
CCH
Comprehensive
Concluded
26-nov-2022
View
Details
CG 25-369; IRGACURE 369; TK 11-319
404-360-3
119313-12-1
CCH
Comprehensive
Concluded
26-nov-2022
View
Details
CG 25-369; IRGACURE 369; TK 11-319
404-360-3
119313-12-1
CCH
Comprehensive
Concluded
26-nov-2022
View
Details
CG 25-369; IRGACURE 369; TK 11-319
404-360-3
119313-12-1
CCH
Comprehensive
Concluded
26-nov-2022
View
Details
CG 25-369; IRGACURE 369; TK 11-319
404-360-3
119313-12-1
CCH
Targeted
Under assessment
12-mar-2024
View
Details
203-452-9
107-01-7
CCH
Targeted
Concluded
26-nov-2022
View
Details
203-452-9
107-01-7
TPE
Testing Proposal
Under assessment
09-jun-2022
View
Details
286-304-6
85204-10-0
CCH
Comprehensive
Concluded
26-nov-2022
View
Details
236-885-7
13532-94-0
CCH
Comprehensive
Under assessment
08-feb-2024
View
Details
259-210-8
54546-26-8
CCH
Targeted
Concluded
26-nov-2022
View
Details
2-BUTYL-4-CHLORO-5-FORMYLIMIDAZOLE; BCFI
410-260-0
83857-96-9
CCH
Targeted
Concluded
26-nov-2022
View
Details
203-904-5
111-75-1
TPE
Testing Proposal
Concluded
26-nov-2022
View
Details
264-980-3
64628-44-0
TPE
Testing Proposal
Concluded
26-nov-2022
View
Details
201-174-2
79-07-2
CCH
Comprehensive
Concluded
26-nov-2022
View
Details
204-818-0
126-99-8
CCH
Targeted
Concluded
26-nov-2022
View
Details
200-858-8
75-29-6
TPE
Testing Proposal
Concluded
26-nov-2022
View
Details
202-424-3
95-49-8
CCH
Targeted
Concluded
26-nov-2022
View
Details
202-424-3
95-49-8
CCH
Targeted
Concluded
26-nov-2022
View
Details
202-424-3
95-49-8
CCH
Comprehensive
Concluded
26-abr-2023
View
Details
423-740-1
10461-98-0
CCH
Comprehensive
Concluded
01-mar-2024
View
Details
423-740-1
10461-98-0
CCH
Comprehensive
Ongoing
24-ago-2023
View
Details
423-740-1
10461-98-0
CCH
Comprehensive
Concluded
31-jul-2023
View
Details
203-057-1
102-81-8
TPE
Testing Proposal
Concluded
26-nov-2022
View
Details
220-688-8
2867-47-2
CCH
Targeted
Concluded
26-nov-2022
View
Details
220-688-8
2867-47-2
CCH
Targeted
Concluded
26-nov-2022
View
Details
259-370-9
54839-24-6
CCH
Comprehensive
Concluded
26-nov-2022
View
Details
618-804-0
919-94-8
CCH
Targeted
Concluded
26-nov-2022
View
Details
211-309-7
637-92-3
CCH
Targeted
Concluded
26-nov-2022
View
Details
211-309-7
637-92-3
CCH
Targeted
Concluded
26-nov-2022
View
Details
205-130-3
134-11-2
CCH
Comprehensive
Concluded
26-nov-2022
View
Details
C.I. DISPERSE RED 367
403-960-2
147014-52-6
CCH
Targeted
Concluded
26-nov-2022
View
Details
C.I. DISPERSE RED 367
403-960-2
147014-52-6
TPE
Testing Proposal
Ongoing
29-nov-2023
View
Details
613-848-7
65870-94-2
CCH
Comprehensive
Concluded
26-nov-2022
View
Details
251-336-1
33007-83-9
TPE
Testing Proposal
Concluded
26-nov-2022
View
Details
203-797-5
110-73-6
TPE
Testing Proposal
Concluded
26-nov-2022
View
Details
203-234-3
104-76-7
CCH
Targeted
Concluded
26-nov-2022
View
Details
278-031-6
74931-55-8
CCH
Comprehensive
Under assessment
13-sep-2023
View
Details
629-661-9
83834-59-7
TPE
Testing Proposal
22-sep-2021
View
Details
239-622-4
15571-58-1
TPE
Testing Proposal
Concluded
26-nov-2022
View
Details
239-622-4
15571-58-1
TPE
Testing Proposal
Under assessment
10-nov-2023
View
Details
260-828-5
57583-34-3
CCH
Comprehensive
Concluded
26-nov-2022
View
Details
248-227-6
27107-89-7
TPE
Testing Proposal
Concluded
26-nov-2022
View
Details
248-227-6
27107-89-7
TPE
Testing Proposal
Concluded
26-nov-2022
View
Details
248-227-6
27107-89-7
CCH
Comprehensive
Concluded
26-nov-2022
View
Details
263-471-3
62256-00-2
CCH
Comprehensive
Concluded
30-ene-2023
View
Details
203-080-7
103-11-7
TPE
Testing Proposal
Under assessment
08-sep-2023
View
Details
226-641-8
5444-75-7
CCH
Comprehensive
Concluded
26-nov-2022
View
Details
214-987-2
1241-94-7
CCH
Targeted
Concluded
26-nov-2022
View
Details
214-987-2
1241-94-7
CCH
Targeted
Concluded
26-nov-2022
View
Details
214-987-2
1241-94-7
CCH
Targeted
Concluded
26-nov-2022
View
Details
240-447-0
16397-75-4
TPE
Testing Proposal
Under assessment
06-sep-2023
Details
228-503-2
6283-86-9
CCH
Targeted
Concluded
26-nov-2022
View
Details
228-503-2
6283-86-9
CCH
Comprehensive
Concluded
11-ago-2023
View
Details
243-697-9
20292-08-4
TPE
Testing Proposal
Concluded
26-nov-2022
View
Details
211-708-6
688-84-6
CCH
Targeted
Under assessment
09-nov-2023
View
Details
211-708-6
688-84-6
TPE
Testing Proposal
Concluded
26-nov-2022
View
Details
248-363-6
27247-96-7
TPE
Testing Proposal
Under assessment
12-ene-2023
View
Details
248-363-6
27247-96-7
CCH
Targeted
Concluded
26-nov-2022
View
Details
247-655-0
26399-02-0
TPE
Testing Proposal
Concluded
26-nov-2022
View
Details
201-803-0
88-14-2
CCH
Comprehensive
Concluded
03-mar-2023
View
Details
219-370-1
2425-77-6
TPE
Testing Proposal
Concluded
26-nov-2022
View
Details
1 - 2.5 moles ethoxylated
500-116-6
52609-19-5
CCH
Targeted
Concluded
26-nov-2022
View
Details
1 - 2.5 moles ethoxylated
500-116-6
52609-19-5
CCH
Comprehensive
Concluded
26-nov-2022
View
Details
246-885-9
25354-97-6
CCH
Comprehensive
Under assessment
13-sep-2023
View
Details
203-951-1
112-25-4
TPE
Testing Proposal
25-oct-2023
View
Details
203-951-1
112-25-4
TPE
Testing Proposal
Concluded
03-nov-2023
View
Details
444-860-9
474510-57-1
CCH
Comprehensive
Under assessment
12-mar-2024
View
Details

Export search results to: